SABRE-B: an evaluation of paclitaxel and bevacizumab with or without sunitinib as first-line treatment of metastatic breast cancer (Q43055420)

From Wikidata
Jump to navigation Jump to search
scientific article published on 23 May 2010
edit
Language Label Description Also known as
English
SABRE-B: an evaluation of paclitaxel and bevacizumab with or without sunitinib as first-line treatment of metastatic breast cancer
scientific article published on 23 May 2010

    Statements

    SABRE-B: an evaluation of paclitaxel and bevacizumab with or without sunitinib as first-line treatment of metastatic breast cancer (English)
    23 May 2010
    2370-2376

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit